• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


Karl Storz

Anonymous board for Karl Storz
Replies
0
Views
953
anonymous
Replies
4
Views
4K
anonymous
Replies
6
Views
5K
anonymous
Replies
2
Views
3K
anonymous
Replies
1
Views
2K
anonymous
Replies
5
Views
4K
anonymous
Replies
19
Views
7K
anonymous
Replies
5
Views
4K
anonymous
Replies
4
Views
2K
anonymous
Replies
460
Views
118K
anonymous
Replies
21
Views
10K
anonymous
Replies
29
Views
26K
anonymous
Replies
10
Views
4K
anonymous
Replies
2
Views
2K
anonymous
Replies
6
Views
3K
anonymous